Skip to content

Effect of homoeopathic medicines in the cases of metabolic syndrome among adults

Effect of individualized homoeopathic medicines in the cases of metabolic syndrome among adult population- a prospective pre-post clinical study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077758
Enrollment
47
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E88- Other and unspecified metabolic disorders

Interventions

Intervention1: Homoeopathic Medicines: Oral Route of Administration centesimal scale pill form size 30 First dose at the time of case taking subsequent doses according to follow ups In L M Potency or

Sponsors

Bakson homoeopathic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants in the age group between 18 to 54 years and all genders Diagnostic criteria If any 3 conditions of the criteria given below is found in a participant he/she will be included in the study Triglyceride level more than 150 mg/dl (Mild hypertriglyceridemia 150 to 499 mg/dL) HDL level low less than 40 mg/dl Blood pressure more than 130/85 mmHg (stage 1 and stage 2) Fasting blood glucose level more than 120 to 240 mg/dl BMI obesity class1 BMI 30 to 34.9 kg/meter square Participants willing to give consent will be included

Exclusion criteria

Exclusion criteria: Participants with other severe systemic illness requiring emergency care and who are immune compromised Pregnant and lactating women Participants who have taken any homoeopathic medicines for last 3 months Participants with any substance use disorder and severe mental disorder

Design outcomes

Primary

MeasureTime frame
Changes will be observed in MSSS scale. Changes can be positive or negative or no change.Timepoint: 15 months Enrolment-6 months Follow up- 6 months Statistical analysis- 3 months First dose will be given after case taking. Subsequent doses as per the follow ups. MSSS scale will be used at baseline at 3 months and at 6 months.

Secondary

MeasureTime frame
NILTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr Ashwini Nair

Bakson Homoeopathic Medical College and Hospital

vijaya84goswami@yahoo.com9899602004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026